Imatinib mesylate inhibits platelet derived growth factor stimulated proliferation of rheumatoid synovial fibroblasts |
| |
Authors: | Sandler Charlotta Joutsiniemi Saima Lindstedt Ken A Juutilainen Timo Kovanen Petri T Eklund Kari K |
| |
Institution: | Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital, Finland. |
| |
Abstract: | Synovial fibroblast is the key cell type in the growth of the pathological synovial tissue in arthritis. Here, we show that platelet-derived growth factor (PDGF) is a potent mitogen for synovial fibroblasts isolated from patients with rheumatoid arthritis. Inhibition of PDGF-receptor signalling by imatinib mesylate (1muM) completely abrogated the PDGF-stimulated proliferation and inhibited approximately 70% of serum-stimulated proliferation of synovial fibroblasts. Similar extent of inhibition was observed when PDGF was neutralized with anti-PDGF antibodies, suggesting that imatinib mesylate does not inhibit pathways other than those mediated by PDGF-receptors. No signs of apoptosis were detected in synovial fibroblasts cultured in the presence of imatinib. These results suggest that imatinib mesylate specifically inhibits PDGF-stimulated proliferation of synovial fibroblasts, and that inhibition of PDGF-receptors could represent a feasible target for novel antirheumatic therapies. |
| |
Keywords: | Imatinib mesylate Rheumatoid arthritis Synovial fibroblast |
本文献已被 ScienceDirect PubMed 等数据库收录! |